Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity
100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity buy - large image1
100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity buy - image1
100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity buy - image2
100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity buy - image3
100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity buy - image4
100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity buy - image5
100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity buy - image6

100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity

TDS 7503 Inquiries

Unit Price:

$78/MT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

GZ

Brand:

CaoQuan

Packaging:

5/10/15/20/30mg/vial,10vial/box

Sample Available:

Yes

Price valid (until):

2027-05-27

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

Cagrilintide,Tirzepatide,Semaglutide,Retatrutide,NAD+,Melatonine

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Sales manager:Ava
    whatsapp:+8617325602040
    Email:17325602040@163.com

    sincerely look forward to your inquiries about our products.


      Product Detail  


    Retatrutide operates through a unique mechanism as a triple agonist, targeting the , GLP-1, and GCG receptors, with a strong emphasis on GIP receptor activation. This receptor interaction leads to a comprehensive approach to metabolic regulation, significantly impacting both glycemic control and weight loss. Below is an overview of the underlying mechanisms:

    • Retatrutide's primary mechanism involves potent activation of the GIP receptor, which plays a vital role in appetite regulation by directly affecting the brain's satiety centers. This reduces hunger, cravings, and overall food intake.
    • Through GLP-1 receptor activation, retatrutide supports glycemic regulation and enhances satiety. GLP-1 also slows down gastrointestinal motility and delays gastric emptying, leading to increased feelings of fullness after meals.
    • Activation of the GCG receptor by retatrutide is believed to increase energy expenditure and promote fat oxidation, largely through metabolic actions in the liver. GCG receptor stimulation encourages fat breakdown and elevates metabolic rates. Additionally, it induces "beiging" of white fat, converting it into beige fat with thermogenic properties similar to brown fat, thereby boosting calorie burning and enhancing metabolism.  


    Items Specifications
    Product Name Retatrutide
    Purity >99%
    Appearance White lyophilized powder
    CAS NO. 2381089-83-2

    Shop 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity-Detailed Image 1 Shop 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity-Detailed Image 2 Shop 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity-Detailed Image 3


      Product effects  


    • Weight loss
    • Helps lower blood sugar
    • Slows gastric emptying
    • Improved metabolism
    • Muscle building
    • Improve metabolic indicators such as blood glucose and blood lipids, and reduce the risk of cardiovascular disease.

    Shop 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity-Detailed Image 4



      Company Profile  


    Changsha Caoquan Technology Co., Ltd. is a high-tech company specializing in the research and development and production of polypeptide drugs. The company has an advanced industrial chain, covering the research and development, approval and industrialization of peptide raw materials and preparations. Its products include innovative drugs, raw materials, enzymes used in medicine and green synthesis industry, functional peptides and protein products.
    Our core strengths are advanced polypeptide technology, strict quality control (conforming to cGMP standards), professional R&D team, and end-to-end solutions from raw materials to finished products.
    We are committed to providing customers with high-quality and high-value products and services and have established a good reputation in the global market. With excellent product quality, logistics service and customer-centered business philosophy, our products have been exported to more than 100 countries.
    Changsha Cao Quan is willing to maintain cooperative relations with old and new friends and create a better future together!

    Shop 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity-Detailed Image 5

    Shop 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity-Detailed Image 6



    Advantage 


    1. Higher quality products (>=99% purity) for most of peptides and raws. Quality Guaranteed: Many HPLC test reports are available .

    2. Ship worldwide with safe and secure lines: 100% delivery guaranteed. No worry about Customs issues.

    3. Special Service: Drop-shipping if need.

    4. Cheapest prices in the market, unbeatable!
    5. Double-clearance express, safer and more efficient.

    Shop 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity-Detailed Image 7

    FAQ

    Q1: When will the product be shipped after payment?
      ---We are committed to the same day shipping.

    Q2. How does your factory control quality?
    All the raw material purchasing and production quality control are strictly following the ISO9001: 2008 management system. Besides, the full-featured detection equipment and GMP quality management system provided the strongest guarantee for a high-quality product.


    Q3: How long will it take to receive the parcel?
       --3 days for the US market; 4-6 days for the others.

    Q4: What can I do if I don't have the ability to clear the custom?
       --We got experience after doing export for many years, so don't worry we can handle that.


    Packaging & Shipping  


    Shop 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity-Detailed Image 8 Shop 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity-Detailed Image 9 Shop 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity-Detailed Image 10

    If you would like to inquire about other peptides, please contact me!

    Sales manager:Ava
    whatsapp:+8617325602040
    Email:17325602040@163.com

    sincerely look forward to your inquiries about our products.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates
    • 100% Good Feedback Retatrutide weight loss 10mg Retatrutide CAS 2381089-83-2 99% and above 99% purity Certificates 1 TDS

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Cagrilintide,Tirzepatide,Semaglutide,Retatrutide,NAD+,Melatonine

    Location:

    Room 102, No. 60-20, Gongnong Street, Xiangya Road Subdistrict, Kaifu District, Changsha City, Hunan Province, China

    Payment Terms:

    TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    1 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    Company Certificates
    • Changsha Caoquan Biotechnology Co., Ltd.Certificate Certificate
    • Changsha Caoquan Biotechnology Co., Ltd.Certificate Certificate
  • Inquiry History
    7503 Inquiries
    Country Product Purchase Quantity Date Posted
    Malaysia

    Retatrutide

    20 MG Oct 28, 2026
    Australia

    Retaturtide

    100 MG Oct 29, 2026
    United States

    Retatrutide 30mg and 50mg

    20 PCS Oct 29, 2026
    Belgium

    Retatrutide

    1 MG Oct 29, 2026
    Romania

    Retatrutide

    10 G Oct 29, 2026
    United States

    Retatrutide

    2 MT Oct 29, 2026
    United States

    Retatrutide

    1 MT Oct 29, 2026
    United Kingdom

    Retatrutide

    1 PCS Oct 28, 2026
    United States

    Retatrutide

    30 MT Oct 28, 2026
    United Kingdom

    Retatrutide

    10 MT Oct 28, 2026
    United States

    retatrutide

    30 MG Oct 28, 2026
    Czech

    Retatrutide

    10 MG Oct 28, 2026
    Austria

    retatrutide

    30 MG Oct 28, 2026
    United States

    Retatrutide

    100 KG Oct 28, 2026
    Malta

    Retatrutide

    10 MT Oct 28, 2026
    United States

    Retatrutide

    600 MG Oct 28, 2026
    United States

    Retatrutide

    500 G Oct 28, 2026
    United States

    Retatrutide

    60 G Oct 28, 2026
    Croatia

    Retatrutide

    10 MG Oct 28, 2026
    United States

    Retatrutide

    200 MG Oct 28, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.